Timik karsinoid tümörler nadir tümörler olup, multipl endokrin neoplazi tip 1 ile birlikte görülebilirler. Bronşiyal karsinoidler de nadir tümörler olup, multipl endokrin neoplazi tip 1’e eşlik edebilirler. Bu durumda timik ve bronşiyal karsinoid tümörlerin birlikteliği oldukça enderdir. Bu yazıda, torakotomi ile eş zamanlı rezeke edilen timik ve bronşiyal karsinoid tümörlerin benzersiz bir birlikteliği olgusu sunuldu.
Thymic carcinoid tumors are rare tumors which may beassociated with multiple endocrine neoplasia type 1. Bronchialcarcinoids are also rare tumors and associated with multipleendocrine neoplasia type 1. Coexisting of thymic and bronchialcarcinoid tumors in this case is extremely rare. Herein, we reporta unique case of coexistence of thymic and bronchial carcinoidtumors which were simultaneously resected via thoracotomy. ">
[PDF] Multipl endokrin neoplazi tip 1 tanılı bir hastada timik ve bronşiyal karsinoid tümörlerin eş zamanlı rezeksiyonu | [PDF] Simultaneous resection of thymic and bronchial carcinoid tumors in a patient diagnosed with multiple endocrine neoplasia type 1
Timik karsinoid tümörler nadir tümörler olup, multipl endokrin neoplazi tip 1 ile birlikte görülebilirler. Bronşiyal karsinoidler de nadir tümörler olup, multipl endokrin neoplazi tip 1’e eşlik edebilirler. Bu durumda timik ve bronşiyal karsinoid tümörlerin birlikteliği oldukça enderdir. Bu yazıda, torakotomi ile eş zamanlı rezeke edilen timik ve bronşiyal karsinoid tümörlerin benzersiz bir birlikteliği olgusu sunuldu. ">
Timik karsinoid tümörler nadir tümörler olup, multipl endokrin neoplazi tip 1 ile birlikte görülebilirler. Bronşiyal karsinoidler de nadir tümörler olup, multipl endokrin neoplazi tip 1’e eşlik edebilirler. Bu durumda timik ve bronşiyal karsinoid tümörlerin birlikteliği oldukça enderdir. Bu yazıda, torakotomi ile eş zamanlı rezeke edilen timik ve bronşiyal karsinoid tümörlerin benzersiz bir birlikteliği olgusu sunuldu.
Thymic carcinoid tumors are rare tumors which may beassociated with multiple endocrine neoplasia type 1. Bronchialcarcinoids are also rare tumors and associated with multipleendocrine neoplasia type 1. Coexisting of thymic and bronchialcarcinoid tumors in this case is extremely rare. Herein, we reporta unique case of coexistence of thymic and bronchial carcinoidtumors which were simultaneously resected via thoracotomy. ">
Multipl endokrin neoplazi tip 1 tanılı bir hastada timik ve bronşiyal karsinoid tümörlerin eş zamanlı rezeksiyonu
Timik karsinoid tümörler nadir tümörler olup, multipl endokrin neoplazi tip 1 ile birlikte görülebilirler. Bronşiyal karsinoidler de nadir tümörler olup, multipl endokrin neoplazi tip 1’e eşlik edebilirler. Bu durumda timik ve bronşiyal karsinoid tümörlerin birlikteliği oldukça enderdir. Bu yazıda, torakotomi ile eş zamanlı rezeke edilen timik ve bronşiyal karsinoid tümörlerin benzersiz bir birlikteliği olgusu sunuldu.
Simultaneous resection of thymic and bronchial carcinoid tumors in a patient diagnosed with multiple endocrine neoplasia type 1
Thymic carcinoid tumors are rare tumors which may beassociated with multiple endocrine neoplasia type 1. Bronchialcarcinoids are also rare tumors and associated with multipleendocrine neoplasia type 1. Coexisting of thymic and bronchialcarcinoid tumors in this case is extremely rare. Herein, we reporta unique case of coexistence of thymic and bronchial carcinoidtumors which were simultaneously resected via thoracotomy.
1. Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H,
Ebeling PR, et al. Clinical practice guidelines for multiple
endocrine neoplasia type 1 (MEN1). J Clin Endocrinol
Metab 2012;97:2990-3011.
2. Ferguson MK, Saha-Chaudhuri P, Mitchell JD, Varela
G, Brunelli A. Prediction of major cardiovascular events
after lung resection using a modified scoring system.
Ann Thorac Surg 2014;97:1135-40.
3. Singh Ospina N, Thompson GB, C Nichols F, Cassivi SD,
Young WF Jr. Thymic and Bronchial Carcinoid Tumors
in Multiple Endocrine Neoplasia Type 1: The Mayo Clinic
Experience from 1977 to 2013. Horm Cancer 2015;6:247-53.
4. Sachithanandan N, Harle RA, Burgess JR. Bronchopulmonary
carcinoid in multiple endocrine neoplasia type 1. Cancer
2005;103:509-15.
5. Gibril F, Chen YJ, Schrump DS, Vortmeyer A, Zhuang Z,
Lubensky IA, et al. Prospective study of thymic carcinoids
in patients with multiple endocrine neoplasia type 1. J Clin
Endocrinol Metab 2003;88:1066-81.
6. Sugiura H, Morikawa T, Itoh K, Ono K, Okushiba S,
Kondo S, et al. Thymic carcinoid in a patient with multiple
endocrine neoplasia type 1: report of a case. Surg Today
2001;31:428-32.
7. Ferolla P, Falchetti A, Filosso P, Tomassetti P, Tamburrano
G, Avenia N, et al. Thymic neuroendocrine carcinoma
(carcinoid) in multiple endocrine neoplasia type 1 syndrome:
the Italian series. J Clin Endocrinol Metab 2005;90:2603-9.
8. de Laat JM, Pieterman CR, van den Broek MF, Twisk JW,
Hermus AR, Dekkers OM, et al. Natural course and survival
of neuroendocrine tumors of thymus and lung in MEN1
patients. J Clin Endocrinol Metab 2014;99:3325-33.
9. Wilkinson S, Teh BT, Davey KR, McArdle JP, Young M,
Shepherd JJ. Cause of death in multiple endocrine neoplasia
type 1. Arch Surg 1993;128:683-90.
10. Teh BT, McArdle J, Chan SP, Menon J, Hartley L, Pullan
P, et al. Clinicopathologic studies of thymic carcinoids in
multiple endocrine neoplasia type 1. Medicine (Baltimore)
1997;76:21-9.
11. Shepherd JJ. The natural history of multiple endocrine
neoplasia type 1. Highly uncommon or highly unrecognized?
Arch Surg 1991;126:935-52.
12. Lin F, Xiao Z, Mei J, Liu C, Pu Q, Ma L, et al. Simultaneous
thoracoscopic resection for coexisting pulmonary and thymic
lesions. J Thorac Dis 2015;7:1637-42.
13. Patella M, Anile M, Vitolo D, Venuta F. Synchronous B3
thymoma and lung bronchoalveolar carcinoma. Interact
Cardiovasc Thorac Surg 2011;12:75-6.
14. Dolci G, Dell'Amore A, Asadi N, Caroli G, Greco D, Stella
F, et al. Synchronous thymoma and lung adenocarcinoma
treated with a single mini-invasive approach. Heart Lung
Circ 2015;24:11-3.
15. Benveniste MF, Korst RJ, Rajan A, Detterbeck FC, Marom
EM; International Thymic Malignancy Interest Group. A
practical guide from the International Thymic Malignancy
Interest Group (ITMIG) regarding the radiographic
assessment of treatment response of thymic epithelial tumors
using modified RECIST criteria. J Thorac Oncol 2014;9(9
Suppl 2):S119-24.